Targeting the PD-1/PD-L1 pathway in glioblastoma multiforme: Preclinical evidence and clinical interventions.
Sign Up to like & getrecommendations! Published in 2021 at "International immunopharmacology"
DOI: 10.1016/j.intimp.2021.107403
Abstract: Glioblastoma multiforme (GBM), as one of the immunosuppressive and common intrinsic brain tumors in adults, remains an intractable malignancy to manage. Since the standard of care for treatment, which includes surgery and chemoradiation, has not… read more here.
Keywords: multiforme preclinical; glioblastoma multiforme; preclinical evidence; targeting pathway ... See more keywords
The STAT3-Regulated Autophagy Pathway in Glioblastoma
Sign Up to like & getrecommendations! Published in 2023 at "Pharmaceuticals"
DOI: 10.3390/ph16050671
Abstract: Glioblastoma (GBM) is the most common primary brain malignancy in adults with a dismal prognosis. Despite advances in genomic analysis and surgical technique and the development of targeted therapeutics, most treatment options are ineffective and… read more here.
Keywords: regulated autophagy; gbm; autophagy pathway; stat3 regulated ... See more keywords